Centese Handedly Beats the Odds, Soars toward Scale!

As medical device founders know, the failure rate is high. Amongst the highest for nearly all business types with between 75-90% estimated to collapse before reaching commercialization. The odds were certainly stacked against Centese as they pursued scalable commercialization.

Our hat is tipped to the entire Centese team, particularly cofounders Evan Luxon and Randy Preston, who recently celebrated a major company milestone: officially launching Thoragaurd commercially with millions in revenue already earned.

No small feat for any business owner and a particularly challenging endeavor in a highly regulated, hard-to-breakthrough industry. Cheers to you all!

We’re buckled up and ready for take off! Let’s goooooo!